Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) Amortizatization of Intangibles: 2010-2019

Historic Amortizatization of Intangibles for EyePoint Pharmaceuticals (EYPT) over the last 8 years, with Dec 2019 value amounting to $656,000.

  • EyePoint Pharmaceuticals' Amortizatization of Intangibles rose 6.84% to $656,000 in Q4 2019 from the same period last year, while for Dec 2019 it was $2.5 million, marking a year-over-year increase of 23.33%. This contributed to the annual value of $2.0 million for FY2022, which is 18.00% down from last year.
  • Latest data reveals that EyePoint Pharmaceuticals reported Amortizatization of Intangibles of $656,000 as of Q4 2019, which was up 6.67% from $615,000 recorded in Q1 2019.
  • In the past 5 years, EyePoint Pharmaceuticals' Amortizatization of Intangibles ranged from a high of $656,000 in Q4 2019 and a low of $180,000 during Q4 2016.
  • For the 3-year period, EyePoint Pharmaceuticals' Amortizatization of Intangibles averaged around $426,889, with its median value being $614,000 (2018).
  • As far as peak fluctuations go, EyePoint Pharmaceuticals' Amortizatization of Intangibles fell by 5.26% in 2016, and later surged by 237.91% in 2018.
  • Quarterly analysis of 5 years shows EyePoint Pharmaceuticals' Amortizatization of Intangibles stood at $190,000 in 2015, then decreased by 5.26% to $180,000 in 2016, then grew by 1.67% to $183,000 in 2017, then skyrocketed by 235.52% to $614,000 in 2018, then rose by 6.84% to $656,000 in 2019.
  • Its Amortizatization of Intangibles was $656,000 in Q4 2019, compared to $615,000 in Q1 2019 and $614,000 in Q4 2018.